{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:49:29Z","timestamp":1776620969242,"version":"3.51.2"},"reference-count":26,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Gilead","award":["GLD22\/00032"],"award-info":[{"award-number":["GLD22\/00032"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,6,12]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The evaluation of staging and activity of invasive fungal infection (IFI) is used to adjust the type and duration of antifungal therapy (AT). Typically anatomy-based imaging is used. Positron emission tomography\/CT with\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) not only evaluates more than one body area in one session, but adds functional information to the anatomic data provided by usual imaging techniques and can potentially improve staging of IFI and monitoring of the response to therapy. Our objective is to analyse the impact of the systematic use of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in IFI diagnostic and therapeutic management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      Multicentre prospective cohort study of IFI with performance of systematic\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT at diagnosis and follow-up that will be carried out in 14 Spanish tertiary hospitals. It is planned to include 224 patients with IFI over a 2-year study period. Findings and changes in management before and after\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT will be compared. Additionally, the association of initial quantitative\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT parameters with response to therapy will be evaluated.\n                    <\/jats:p>\n                    <jats:p>\n                      The primary endpoint is to compare the yield of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT with standard management without\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT in IFI at initial assessment (staging) and in monitoring the response to treatment.\n                    <\/jats:p>\n                    <jats:p>\n                      The impact of the results of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT on the diagnostic-therapeutic management of patients with IFI (added value), as well as the prognostic ability of different quantification parameters of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT will be secondary endpoints.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Clinical Research Ethics Committee of Puerta de Hierro-Majadahonda University Hospital approved the protocol of the study at the primary site. We plan to publish the results in high-impact journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05688592\">NCT05688592<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-074240","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T02:23:14Z","timestamp":1687573394000},"page":"e074240","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Determining the usefulness of systematic\n                    <sup>18<\/sup>\n                    F-FDG PET\/CT for the management of invasive fungal infection (PETIFI project): a prospective national multicentre cohort study protocol"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05688592","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-6779","authenticated-orcid":false,"given":"Andrea","family":"Guti\u00e9rrez","sequence":"first","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Velasquez","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"M\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Calder\u00f3n-Parra","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-8348","authenticated-orcid":false,"given":"Alejandro","family":"Callejas-Diaz","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-9425","authenticated-orcid":false,"given":"Antonio","family":"Ramos-Martinez","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-1120","authenticated-orcid":false,"given":"Ana","family":"Fernandez-Cruz","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"2025121220495755000_13.6.e074240.1","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11010137","article-title":"The added value of [18F]FDG PET\/CT in the management of invasive fungal infections","volume":"11","author":"Ankrah","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2025121220495755000_13.6.e074240.2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-018-4062-8","article-title":"FDG PET\/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging","volume":"46","author":"Douglas","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025121220495755000_13.6.e074240.3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025121220495755000_13.6.e074240.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.01.701"},{"key":"2025121220495755000_13.6.e074240.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00062206"},{"key":"2025121220495755000_13.6.e074240.6","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30847-1"},{"key":"2025121220495755000_13.6.e074240.7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025121220495755000_13.6.e074240.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.112524"},{"key":"2025121220495755000_13.6.e074240.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"2025121220495755000_13.6.e074240.10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1381612824666171213101648","article-title":"The role of PET in monitoring therapy in fungal infections","volume":"24","author":"Ankrah","year":"2018","journal-title":"CPD"},{"key":"2025121220495755000_13.6.e074240.11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2025121220495755000_13.6.e074240.12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2018.03.018","article-title":"Executive summary of clinical practice guideline for the management of invasive diseases caused by aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI","volume":"37","author":"Garcia-Vidal","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"2025121220495755000_13.6.e074240.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"2025121220495755000_13.6.e074240.14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933"},{"key":"2025121220495755000_13.6.e074240.15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciaa666","article-title":"Impact of systematic whole-body 18F-fluorodeoxyglucose PET\/CT on the management of patients suspected of infective endocarditis: the prospective multicenter tepvendo study","volume":"73","author":"Duval","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025121220495755000_13.6.e074240.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases","volume":"18 Suppl 7","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2025121220495755000_13.6.e074240.17","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0053"},{"key":"2025121220495755000_13.6.e074240.18","first-page":"255","article-title":"An update on the role of (18)F-FDG-PET\/CT in major infectious and inflammatory diseases","volume":"9","author":"Kung","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2025121220495755000_13.6.e074240.19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12879-021-05958-3","article-title":"Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response","volume":"21","author":"Neofytos","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025121220495755000_13.6.e074240.20","doi-asserted-by":"publisher","DOI":"10.1086\/590566"},{"key":"2025121220495755000_13.6.e074240.21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/cid\/ciz1195","article-title":"How long do we need to treat an invasive mold disease in hematology patients? Factors influencing duration of therapy and future questions","volume":"71","author":"Fern\u00e1ndez-Cruz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025121220495755000_13.6.e074240.22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.semnuclmed.2017.10.004","article-title":"Monitoring response to therapy","volume":"48","author":"Sathekge","year":"2018","journal-title":"Semin Nucl Med"},{"key":"2025121220495755000_13.6.e074240.23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40336-021-00445-w","article-title":"State of the art of 18F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation","volume":"9","author":"Casali","year":"2021","journal-title":"Clin Transl Imaging"},{"key":"2025121220495755000_13.6.e074240.24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10096-015-2384-z","article-title":"The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort","volume":"34","author":"Fern\u00e1ndez-Cruz","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025121220495755000_13.6.e074240.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.192062"},{"key":"2025121220495755000_13.6.e074240.26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00259-019-04571-6","article-title":"Diagnostic performance of 18F-FDG PET\/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis","volume":"47","author":"Treglia","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-074240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:50:07Z","timestamp":1765601407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-074240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,23]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjopen-2023-074240"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-074240","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}